Androgen Deprivation Therapy Not Found to Increase Risk of Dementia, Alzheimer’s

Androgen Deprivation Therapy Not Found to Increase Risk of Dementia, Alzheimer’s
Prostate cancer patients receiving androgen deprivation therapy (ADT) are not at increased risk of dementia or Alzheimer’s disease, according to a study in the Journal of Clinical Oncology. ADT involves depriving patients of androgen hormones such as testosterone, which are necessary for prostate cancer cells to grow. It is the preferred treatment for patients with

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *